Medical Device Reporting (MDR) Requirements the New FDA Draft Guidance

Size: px
Start display at page:

Download "Medical Device Reporting (MDR) Requirements the New FDA Draft Guidance"

Transcription

1 Medical Device Reporting (MDR) Requirements the New FDA Draft Guidance February 27, 2014 Jeffrey K. Shapiro (202)

2 Essential Requirements n Submit MDR reportable events to FDA (21 CFR (c), ) n Establish and maintain written procedures to review complaints for MDR reportability (21 CFR , ) n Establish and maintain complete MDR files (21 CFR , ) 2

3 Definition of Reportable Event (21 CFR 803.3) n MDR reportable event (or reportable event) means: An event that manufacturers or importers become aware of that reasonably suggests that one of their marketed devices: (i) May have caused or contributed to a death or serious injury, or (ii) Has malfunctioned and that the device or a similar device marketed by the manufacturer or importer would be likely to cause or contribute to a death or serious injury if the malfunction were to recur. 3

4 Elements of an MDR Reportable Event n Manufacturer n becomes aware of information n that reasonably suggests n one of its marketed devices n may have caused or contributed to a serious injury or death OR n malfunctioned and same or similar device would likely cause or contribute to serious injury or death upon if malfunction were to recur 4

5 Preamble statement likely Reporters do not need to assess the likelihood that a malfunction will recur. The fact that the malfunction occurred once leads to the presumption that the malfunction will recur. A malfunction is reportable if any one of the following is true: (1) The chance of a death or serious injury occurring as a result of a recurrence of the malfunction is not remote; 5

6 Draft Guidance likely n If malfunction causes death or serious injury once, it is presumed likely to do so q Subsequent malfunctions must be reported n Must file exemption to lift presumption q Based on investigation of subsequent malfunctions q FDA appears to abandon previous two year presumption guidance 6

7 Requirement to Investigate n Perennial problem sometimes difficult to obtain information, healthcare facility or clinician may be uncooperative n Draft guidance says q Level of effort should relate to nature and severity of the event, rather than just focusing on number of attempts n Many manufacturers have a procedure requiring three attempts q Good faith effort includes at least one written request q Record each attempt and response by reporter 7

8 Requirement to Investigate n Draft guidance recommends focus on q Patient involvement and outcome your ability to capture this information is part of good faith effort q If initial report is for a malfunction, but patient subsequently dies, supplemental report should be submitted for death 8

9 Requirement to Investigate n Draft guidance q Good faith effort does not require specific number of attempts one attempt should be in writing q Try to get the device back n If users do not cooperate, you must still analyze event cannot just close the file n Look at device history, manufacturing processes, similar events 9

10 Exemptions Are Becoming More Important n FDA s position (in warning letters and draft guidance) is that q Manufacturers and importer have duplicate requirement to report death or serious injuries need an exemption to have just one report q Manufacturer and contract manufacturer of the finished device have duplicate reporting requirements absent an exemption n Many firms have allocated responsibility by contract but have not requested exemptions for the nonreporter q This needs to change need a contract allocation and an exemption! 10

11 Delay in Surgery n If your device causes or contributes to a delay in surgery, is it a reportable event? q Maybe! n Draft guidance q Delay not automatically reportable q Need to gather details about impact on the patient s condition to support reporting decision 11

12 Routine Surgical Explants n Draft guidance - not reportable if implant has reached (or is near) its established life expectancy q Unless there is device-related death or serious injury associated with explantation / replacement 12

13 Labeled Incompatibility n Device A s labeling states it is not compatible with Device B n Physician uses them together adverse event n Reportable? q Yes if there is a patient serious injury or death because these are reportable even when caused by user error! q No if there is no patient adverse event but the devices do not work not a malfunction because labeling was not followed, so no malfunction report required 13

14 Diagnostic Devices n If diagnostic device failure indirectly serious injury or death reportable? n Draft guidance yes! 14

15 Difference of Medical Opinion n What is healthcare professionals at facility differ over whether malfunction occurred or device may have caused or contributed to serious injury or death? n Draft guidance says- q You must investigate and determine if information reasonably suggests malfunction / serious injury / death q Evaluate the differences in opinion and explain why you choose one over the other 15

16 Same Patient / Different Days n Draft guidance - same patient experiences adverse events on different days with same device report each as separate submission 16

17 Devices under Investigational Device Exemption (IDE) n Draft guidance q Device X is cleared or approved q Device X is being studied for a second intended use under an IDE q Adverse event occurs in the IDE study n Reportable? q Yes both MDR and IDE reporting requirements apply! 17

18 Foreign Events n Device X is exported under section 801(e) or 802 of the Food, Drug, and Cosmetic Act (so it is not cleared or approved for sale in the US) n Reportable event occurs in the EU n Reportable? q Draft guidance yes but we re going to exercise enforcement discretion q Excepts if a concern has arisen but we ll let you know in writing 18

19 Foreign Events n US manufacturer q Device under IDE study in US q Exported under 801(e) or 802 of the FDCA q Adverse event outside US n Reportable? q Draft guidance yes, but enforcement discretion q But it may be reportable to the IDE program 19

20 Foreign Manufacturer n Draft guidance hypothetical q Foreign manufacturer q US clearance or approval q Marketed outside US q Adverse event outside US n Reportable? q Draft guidance yes even if devices are tweaked to meet different standards outside US q Unless modification is directly involved 20

21 Foreign Manufacturer n Draft guidance hypothetical q Foreign manufacturer q No US clearance or approval, but IDE study q Marketed outside US q Adverse event outside US n Reportable? q Draft guidance no MDR report (might be reportable to IDE program) 21

22 Malfunction Caught Before Use n Draft guidance health care provider notices that device is malfunctioning and intervenes before patient harm can occur n Reportable? q Yes, if it could cause serious injury or death if malfunction were to recur n What if device malfunctions and alarms to alert users? q Draft guidance yes because alarm might not work or there might be no one present to respond 22

23 Sale of 510(k) n Draft guidance hypothetical- q Firm A manufacturers and distributes cleared device q Sells 510(k) to Firm B which takes over manufacture and distribution q Adverse event for device sold by Firm A n Who must report? q Firm A q Or firms could agree that Firm B will report but Firm A needs to apply for an exemption as well 23

24 IMPORTANT LINKS MDR Guidance Document - MDR Preamble Compliance Program Guidance Manual CDRH Learn emdr Draft Guidance utm_campaign=google2&utm_source=fdasearch&utm_medium=website&utm_term=mdr %20Guidance&utm_content=2 24

25 Jeffrey Shapiro (202) Thank You! Visit our firm s top-rated blog: 25

Medical Device Reporting (MDR) 21 CFR Part 803

Medical Device Reporting (MDR) 21 CFR Part 803 Medical Device Reporting (MDR) 21 CFR Part 803 1 Objectives Review applicable sections of 21 CFR 803 and 21 CFR 820 Review and explain MDR reporting requirements Review FDA-483 observation examples 2 Medical

More information

Section 5: Quality Systems Regulation (QSR) and Good Manufacturing Practice (GMP)

Section 5: Quality Systems Regulation (QSR) and Good Manufacturing Practice (GMP) Section 5: Quality Systems Regulation (QSR) and Good Manufacturing Practice (GMP) 1 Quality Systems Regulation (QSR) 2 Quality Systems Regulation (QSR) and Good Manufacturing Practice (GMP) Sets of checks

More information

August 18, 2015. Re: Section 1201 Rulemaking Proposed Exemption for Medical Devices

August 18, 2015. Re: Section 1201 Rulemaking Proposed Exemption for Medical Devices DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 August 18, 2015 Ms. Jacqueline C. Charlesworth General Counsel

More information

Mobile Medical Application Development: FDA Regulation

Mobile Medical Application Development: FDA Regulation Mobile Medical Application Development: FDA Regulation Mobile Medical Applications: Current Environment Currently over 100,000 mobile health related applications are available for download; there is an

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Page 1 of 7 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations

More information

Medical Device Reporting. Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration

Medical Device Reporting. Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration Medical Device Reporting Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration Session Overview Purpose: To provide information about the

More information

Clinical trials for medical devices: FDA and the IDE process

Clinical trials for medical devices: FDA and the IDE process Clinical trials for medical devices: FDA and the IDE process Owen Faris, Ph.D. Deputy Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health,

More information

CAPA - the importance of data analysis

CAPA - the importance of data analysis CAPA - the importance of data analysis Presented by: Sue Jacobs QMS Consulting, Inc. 1 847 359 4456 sue@qmsconsultant.com QMS Consulting, Inc. 2007 1 Topics Regulatory Requirements Design Controls and

More information

JUL 2 2008. Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular Cardiac Therapies 3200 Lakeside Drive Santa Clara, CA 95054-2807

JUL 2 2008. Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular Cardiac Therapies 3200 Lakeside Drive Santa Clara, CA 95054-2807 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service JUL 2 2008 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular

More information

FMEA Failure Risk Scoring Schemes

FMEA Failure Risk Scoring Schemes FMEA Failure Risk Scoring Schemes 1-10 Scoring for Severity, Occurrence and Detection CATEGORY Severity 10 9 8 7 6 5 3 2 1 Hazardous, without warning Hazardous, with warning Very High High Moderate Low

More information

Corrections and Removals 21 CFR Part 806

Corrections and Removals 21 CFR Part 806 Corrections and Removals 21 CFR Part 806 Presented by: Kimberly Lewandowski-Walker Food and Drug Administration Division of Domestic Field Investigations Office of Regulatory Affairs From the Newsroom

More information

ORACLE CONSULTING GROUP

ORACLE CONSULTING GROUP ORACLE CONSULTING GROUP An Official United States Agent Firm for Foreign Establishments CONSULTING MEMORANDUM: DEALING WITH A MEDICAL DEVICE IN THE U.S. 5398 Golder Ranch Rd., Ste. 1 Tucson, Arizona 85739

More information

Topics for today. Issues: Regulatory Obligations Post-marketing Adverse Event Reporting; MDRs and Safety Reports. Post-marketing Submissions

Topics for today. Issues: Regulatory Obligations Post-marketing Adverse Event Reporting; MDRs and Safety Reports. Post-marketing Submissions Issues: Regulatory Obligations Post-marketing Adverse Event Reporting; MDRs and Safety Reports Martha A. Feldman, RAC Drug & Device Development Co., Inc. Topics for today Post-approval requirements for

More information

FDA Regulation of Hearing Aids. Eric A. Mann, MD, PhD Clinical Deputy Director Division of Ophthalmic and ENT Devices ODE/CDRH/FDA

FDA Regulation of Hearing Aids. Eric A. Mann, MD, PhD Clinical Deputy Director Division of Ophthalmic and ENT Devices ODE/CDRH/FDA FDA Regulation of Hearing Aids Eric A. Mann, MD, PhD Clinical Deputy Director Division of Ophthalmic ENT ODE/CDRH/FDA U.S. Food Drug Administration Presentation Outline Overview of device regulations riskbased

More information

Mobile Medical Applications: FDA s Final Guidance. M. Elizabeth Bierman Anthony T. Pavel Morgan, Lewis & Bockius, LLP

Mobile Medical Applications: FDA s Final Guidance. M. Elizabeth Bierman Anthony T. Pavel Morgan, Lewis & Bockius, LLP Mobile Medical Applications: FDA s Final Guidance Michele L. Buenafe M. Elizabeth Bierman Anthony T. Pavel Morgan, Lewis & Bockius, LLP 1 Background FDA has a long-standing policy to regulate any computer

More information

Chapter 8 WHAT THE STATUTE AND REGULATIONS SAY. Combination Products. Key Points

Chapter 8 WHAT THE STATUTE AND REGULATIONS SAY. Combination Products. Key Points Chapter 8 Combination Products Suzanne O Shea, Baker & Daniels, LLP, Indianapolis, IN Key Points A combination product comprises two or more different types of regulated components. It can be a drug/device,

More information

SENTINEL EVENTS AND ROOT CAUSE ANALYSIS

SENTINEL EVENTS AND ROOT CAUSE ANALYSIS HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER SENTINEL EVENTS AND ROOT CAUSE ANALYSIS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO.

More information

G. Recalls. http://www.fda.gov/safety/recalls/industryguidance/ucm129259.htm.

G. Recalls. http://www.fda.gov/safety/recalls/industryguidance/ucm129259.htm. G. Recalls 1. Background When an FDA-regulated product is defective, potentially harmful, or mislabeled, recalling that product removing it from the market or correcting the problem is often the most effective

More information

Breakout Sessions: FDA s Regulation of Mobile Health and Medical Applications

Breakout Sessions: FDA s Regulation of Mobile Health and Medical Applications Breakout Sessions: FDA s Regulation of Mobile Health and Medical Applications 2015 Annual Conference Washington, DC Bakul Patel, Associate Director for Digital Health, Office of Center Director, Center

More information

Medical Device Software

Medical Device Software Medical Device Software Bakul Patel Senior Policy Advisor 1 Overview Medical devices and software Oversight principles and Current approach Trends, Challenges and opportunities Addressing challenges 2

More information

CENTER FOR CONNECTED HEALTH POLICY

CENTER FOR CONNECTED HEALTH POLICY CENTER FOR CONNECTED HEALTH POLICY The Center for Connected Health Policy (CCHP) is a public interest nonprofit organization that develops and advances telehealth policy solutions to promote improvements

More information

http://www.fda.gov/forconsumers/consumerupdates/ucm341344.htm?source=govdelivery.

http://www.fda.gov/forconsumers/consumerupdates/ucm341344.htm?source=govdelivery. 6 Tip-offs to Rip-offs: Don't Fall for Health Fraud Scams The US Food and Drug Administration has published a paper on how we as consumers and avoid getting ripped off by health fraud scams. This paper

More information

Vigilance Reporting. Vicky Medley - Head of QMS, Medical Devices. September 2015. Copyright 2015 BSI. All rights reserved.

Vigilance Reporting. Vicky Medley - Head of QMS, Medical Devices. September 2015. Copyright 2015 BSI. All rights reserved. Vigilance Reporting Vicky Medley - Head of QMS, Medical Devices September 2015 2 Why? 3 protecting and improving public health https://www.gov.uk/government/organisations/medicines-and-healthcareproducts-regulatory-agency/about

More information

PMAs, 510(k)s, and Advanced IDE Topics

PMAs, 510(k)s, and Advanced IDE Topics PMAs, 510(k)s, and Advanced IDE Topics Kenneth J. Cavanaugh Jr., Ph.D. Scientific Reviewer Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health kenneth.cavanaugh@fda.hhs.gov

More information

United States Department of Health and Human Services Findings on the Permissibility of Reporting to Public Health Authorities under HIPAA

United States Department of Health and Human Services Findings on the Permissibility of Reporting to Public Health Authorities under HIPAA United States Department of Health and Human Services Findings on the Permissibility of Reporting to Public Health Authorities under HIPAA Background DISCLOSURES FOR PUBLIC HEALTH ACTIVITIES [45 CFR 164.512(b)]

More information

PROGRAM 7382.845. Field Reporting Requirements

PROGRAM 7382.845. Field Reporting Requirements PROGRAM 7382.845 SUBJECT: INSPECTION OF MEDICAL DEVICE MANUFACTURERS IMPLEMENTATION DATE October 1, 2000 COMPLETION DATE September 30, 2004 DATA REPORTING PRODUCT CODES PRODUCT/ASSIGNMENT CODES 73-91 82845A

More information

Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices

Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document

More information

Marketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice

Marketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice Marketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice Kurt R. Karst Hyman, Phelps & McNamara, P.C. 700 Thirteenth Street, N.W., Suite 1200 Washington, D.C.

More information

The Reporting of Adverse Events in Health Care: Minnesota s Law

The Reporting of Adverse Events in Health Care: Minnesota s Law The Reporting of Adverse Events in Health Care: Minnesota s Law Marie Dotseth, MHA Senior Policy Advisor for Patient Safety Minnesota Department of Health Minnesota Background Minnesota Alliance for Patient

More information

Complaints, Servicing, and FDA Reporting

Complaints, Servicing, and FDA Reporting Complaints, Servicing, and FDA Reporting Dan O Leary CBA, CQA, CQE, CRE, SSBB, CIRM President Ombu Enterprises, LLC Dan@OmbuEnterprises.com www.ombuenterprises.com 603-358-3082 1 Outline Setting the Stage

More information

A New Standard for Medical Device Adverse Event Classification

A New Standard for Medical Device Adverse Event Classification Vol. 5, No. 12, December 2009 Can You Handle the Truth? A New Standard for Medical Device Adverse Event Classification By Nancy J. Stark Adverse events are defined and managed differently in the device

More information

ADMINISTRATIVE POLICY & PROCEDURE RISK MANAGEMENT PLAN (MMCIP)

ADMINISTRATIVE POLICY & PROCEDURE RISK MANAGEMENT PLAN (MMCIP) PAGE #: 1 of 8 CROSS REFERENCES: Administrative Policy PI-01: Unanticipated Adverse Patient Events Administrative Policy PI-04: Patient Safety Plan Administrative Policy PI-07: Incident Reporting System

More information

Guidance Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)

Guidance Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS) Guidance s Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

Regulatory Considerations for Medical Device Software. Medical Device Software

Regulatory Considerations for Medical Device Software. Medical Device Software Medtec Ireland 2015 Wireless Medical Devices Regulatory Considerations for Medical Device Software Kenneth L. Block, RAC October 7, 2015 Galway, Ireland Offices: Dallas, Texas (12 employees) Tokyo, Japan

More information

Recall Communication: Medical Device Model Press Release Ron Brown

Recall Communication: Medical Device Model Press Release Ron Brown Recall Communication: Medical Device Model Press Release Ron Brown SLIDE 1 Welcome to CDRH Learn. CDRH Learn is a training program developed by FDA's Center for Devices and Radiological Health. It's designed

More information

CHAPTER 7 - RECALL ACTIVITIES

CHAPTER 7 - RECALL ACTIVITIES CHAPTER 7 INVESTIGATIONS OPERATIONS MANUAL 2015 CONTENTS CHAPTER 7 - RECALL ACTIVITIES 7.1.1.1 - Recall SUBCHAPTER 7.1 - RECALLS... 368 7.1.1 - DEFINITIONS... 368 7.1.1.1 - Recall... 368 7.1.1.2 - Recall

More information

Medical devices adverse incidents reported to MHRA 2011 to 2013

Medical devices adverse incidents reported to MHRA 2011 to 2013 Medical devices adverse incidents reported to MHRA 2011 to 2013 This summary of medical device adverse incident data replaces the annual reports that we have previously published. Further changes are planned

More information

Medical Software Development. International standards requirements and practice

Medical Software Development. International standards requirements and practice Medical Software Development International standards requirements and practice Food and Drug Administration What? A public health agency Why? Protect American consumers How? By enforcing the Federal Food,

More information

Guidance for Industry Bar Code Label Requirements Questions and Answers

Guidance for Industry Bar Code Label Requirements Questions and Answers Guidance for Industry Bar Code Label Requirements Questions and Answers For questions on the content of this guidance, contact the Center for Drug Evaluation and Research or the Center for Biologics Evaluation

More information

Reporting Adverse Events and Concerns at Stroger Hospital

Reporting Adverse Events and Concerns at Stroger Hospital Reporting Adverse Events and Concerns at Stroger Hospital Case Pt on coumadin comes in for community acquired pneumonia and is started on levaquin After several days, you note a lot of bruising.. You realize

More information

On Behalf of: InTouch Health

On Behalf of: InTouch Health On Behalf of: InTouch Health White Paper FDA Regulation of Mobile Health Technologies The Current Regulatory Framework as Applied to InTouch Health s Telehealth Solutions June 15, 2012; Updated June 15,

More information

IOWA STATE UNIVERSITY Institutional Review Board. Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others

IOWA STATE UNIVERSITY Institutional Review Board. Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others IOWA STATE UNIVERSITY Institutional Review Board Reporting Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others Introduction This policy details the Institutional Review Board

More information

August 21, 2015. TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

August 21, 2015. TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Mr. Iain Alligan Technical

More information

The Mammography Quality Standards Act Final Regulations Document #1

The Mammography Quality Standards Act Final Regulations Document #1 Compliance Guidance The Mammography Quality Standards Act Final Regulations Document #1 Document issued on: March 19, 1999 This document supersedes document Draft Compliance Guidance August 27, 1998 U.S.

More information

SUPPORTING STATEMENT FOR Hearing Aid Devices, Professional and Patient Labeling and Conditions for Sale 21 CFR 801.420 and 801.421 OMB No.

SUPPORTING STATEMENT FOR Hearing Aid Devices, Professional and Patient Labeling and Conditions for Sale 21 CFR 801.420 and 801.421 OMB No. A. JUSTIFICATION SUPPORTING STATEMENT FOR Hearing Aid Devices, Professional and Patient Labeling and Conditions for Sale 21 CFR 801.420 and 801.421 OMB No. 0910-0171 1. Circumstances Making the Collection

More information

American Association of Tissue Banks: Impact on FDA s UDI Final Rule

American Association of Tissue Banks: Impact on FDA s UDI Final Rule American Association of Tissue Banks: Impact on FDA s UDI Final Rule TOPIC INITIAL FDA PROPOSAL AATB COMMENT FDA FINAL RULE (INCLUDING COMMENTS) ISBT 128 FDA noted the presence of GS1 [which uses the Global

More information

MOBILE MEDICAL APPLICATIONS

MOBILE MEDICAL APPLICATIONS October 7, 2013 EVOKE HEALTH POINT OF VIEW MOBILE MEDICAL APPLICATIONS FDA GUIDANCE FOR INDUSTRY FOR MORE INFORMATION: Mark McConaghy, VP, Strategy Evoke Health 267.765.4998 mark.mcconaghy@evokehealth.com

More information

Guidance for Industry

Guidance for Industry Guidance for Industry FDA Export Certificates Submit comments and suggestions regarding this document at anytime to Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane,

More information

Application Submitted on Received on Supplement type NDA 021875/S-005 July 24, 2008 July 25, 2008 Changes Being Effected

Application Submitted on Received on Supplement type NDA 021875/S-005 July 24, 2008 July 25, 2008 Changes Being Effected DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 NDA 021875/S-005, S-008, S-015 SUPPLEMENT APPROVAL Cephalon Inc. Attention: Paul Kirsch Senior Director and Group

More information

Regulatory Landscape For Mobile Medical Apps (MMAs)

Regulatory Landscape For Mobile Medical Apps (MMAs) Regulatory Landscape For Mobile Medical Apps (MMAs) Date: December 6, 2013 Place: Erie County Bar Association, MidDay Learning Program Where value is law. Monika Bhatt mbhatt@hodgsonruss.com Blog: GatewayFDA.com

More information

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF ILLINOIS PEORIA DIVISION

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF ILLINOIS PEORIA DIVISION UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF ILLINOIS PEORIA DIVISION MARCIA OLSON, ) ) Plaintiff, ) ) Case No: v. ) ) HOWMEDICA OSTEONICS CORP. d/b/a ) STRYKER ORTHOPAEDICS, ) JURY TRIAL DEMANDED

More information

Triangle Compounding 11/2/15

Triangle Compounding 11/2/15 Triangle Compounding 11/2/15 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District 60 Eighth Street NE Atlanta, GA 30309 November 2, 2015 VIA UNITED

More information

Manifestation Determinations: Legal and Practical Considerations

Manifestation Determinations: Legal and Practical Considerations CSE Chairpersons Technical Assistance Meeting Manifestation Determinations: Legal and Practical Considerations presented by Susan T. Johns, Esq. Ferrara, Fiorenza, Larrison, Barrett & Reitz, P.C. stjohns@ferrarafirm.com

More information

International Medical Device Regulators Forum (IMDRF) US FDA Center for Devices and Radiological Health - Update

International Medical Device Regulators Forum (IMDRF) US FDA Center for Devices and Radiological Health - Update International Medical Device Regulators Forum (IMDRF) US FDA Center for Devices and Radiological Health - Update Kimberly A. Trautman Associate Director, International Affairs Office of the Center Director

More information

Ministero della Salute

Ministero della Salute Why clinical risk is relevant to patient safety? Workshop on Clinical Risk Management and Management of Adverse Event Belgrade 16-17 December 2013 Dott.ssa Lucia Guidotti Ministry of Health, Department

More information

IACP Comparison of 503A and 503B The Drug Quality and Security Act of 2013

IACP Comparison of 503A and 503B The Drug Quality and Security Act of 2013 Exempt Sections within the Food, Drug, and Cosmetic Act If a "traditional compounder", defined as a licensed pharmacist or licensed physician, meets ALL conditions within Section 503A, the compounder is

More information

The U.S. FDA s Regulation and Oversight of Mobile Medical Applications

The U.S. FDA s Regulation and Oversight of Mobile Medical Applications The U.S. FDA s Regulation and Oversight of Mobile Medical Applications The U.S. FDA s Regulation and Oversight of Mobile Medical Applications As smart phones and portable tablet computers become the preferred

More information

It s all about managing food. Food Recall Plan Template For Food Manufacturers

It s all about managing food. Food Recall Plan Template For Food Manufacturers It s all about managing food. Food Recall Plan Template For Food Manufacturers What to Do In The Event Of a Product Recall Every Food Distributor and Food Manufacturer must track the products they manufacture

More information

Cutting Edge Issues in Health Care Technology & mhealth. Agenda

Cutting Edge Issues in Health Care Technology & mhealth. Agenda Cutting Edge Issues in Health Care Technology & mhealth Vernessa Pollard July 2014 Agenda The Regulatory Landscape Jurisdiction and Authority Over Mobile Health Products Requirements, Compliance and Enforcement

More information

AW Server 510 (k) Summary of Safety and Effectiveness

AW Server 510 (k) Summary of Safety and Effectiveness SEP 2 2008 GE Medical Systems AW Server 510 (k) Summary of Safety and Effectiveness This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR

More information

FOOD FACILITIES REGISTRATION OF. Protecting the U.S. Food Supply. What You Need to Know About

FOOD FACILITIES REGISTRATION OF. Protecting the U.S. Food Supply. What You Need to Know About U.S. Food and Drug Administration Protecting the U.S. Food Supply U.S. Department of Health and Human Services What You Need to Know About REGISTRATION OF FOOD FACILITIES FDA Food Security Information

More information

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER OCCURRENCE VARIANCE REPORT SYSTEM EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES

More information

FDA Regulation of Health IT

FDA Regulation of Health IT FDA Regulation of Health IT September 2014 Marian J. Lee Partner +1 (202) 661 7955 mlee@kslaw.com Agenda FDA s Mobile Medical Applications Guidance FDA Draft Guidance on Medical Device Data Systems (MDDS),

More information

Which Apps Does FDA Regulate?

Which Apps Does FDA Regulate? Which Apps Does FDA Regulate? Bradley Merrill Thompson 2015 EPSTEIN BECKER & GREEN, P.C. ALL RIGHTS RESERVED.. 1 Topics for Discussion Which apps does FDA regulate? Enforcement Discretion Pharma Apps Future

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Medication Guides Adding a Toll-Free Number for Reporting Adverse Events U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research

More information

Guidance for Industry. Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products

Guidance for Industry. Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products Guidance for Industry Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products Small Entity Compliance Guide Written comments and suggestions may be

More information

ADDRESSES SYSTEM LOCATION

ADDRESSES SYSTEM LOCATION Volume 80, Number 28 Wednesday, February 11, 2015 Public Notice 9034; Pages 7671 Privacy Act; System of Records: Medical Records, State-24 SUMMARY: Notice is hereby given that the Department of State proposes

More information

510(k) Summary GlobalMedia Group, LIC. MAY 0 7 2013 CONiM

510(k) Summary GlobalMedia Group, LIC. MAY 0 7 2013 CONiM 510(k) Summary GlobalMedia Group, LIC. MAY 0 7 2013 CONiM Date Prepared: January 8, 2013 Submitter's Information: GlobalMedia Group, LLC 15020 N. 74th St. Scottsdale, AZ 85260 Contact: Nicholas Campbell

More information

TEXAS DEPARTMENT OF STATE HEALTH SERVICES. Executive Summary. Report on Regulation of Laser Hair Removal

TEXAS DEPARTMENT OF STATE HEALTH SERVICES. Executive Summary. Report on Regulation of Laser Hair Removal TEXAS DEPARTMENT OF STATE HEALTH SERVICES Report on Regulation of Laser Hair Removal DAVID L. LAKEY, M.D. COMMISSIONER CHARGE Study the licensing and certification of laser hair removal facilities, including

More information

January 12, 2016. Dear Amy Yang:

January 12, 2016. Dear Amy Yang: DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 12, 2016 Amy

More information

Austin Retina Associates Notice of Health Information Practices

Austin Retina Associates Notice of Health Information Practices Austin Retina Associates Notice of Health Information Practices THIS NOTICE DESCRIBES HOW INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT

More information

FDA Releases Final Cybersecurity Guidance for Medical Devices

FDA Releases Final Cybersecurity Guidance for Medical Devices FDA Releases Final Cybersecurity Guidance for Medical Devices By Jean Marie R. Pechette and Ken Briggs Overview and General Principles On October 2, 2014, the Food and Drug Administration ( FDA ) finalized

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Submitting Debarment Certification Statements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document

More information

Final Guidance on Electronic Source Data in Clinical Investigations Promoting esource Data Capture

Final Guidance on Electronic Source Data in Clinical Investigations Promoting esource Data Capture Final Guidance on Electronic Source Data in Clinical Investigations Promoting esource Data Capture CDER Leonard Sacks, Office of Medical Policy Ron Fitzmartin, Office of Strategic Programs Jonathan Helfgott,

More information

FDA Guidance for Industry Update - Process Validation

FDA Guidance for Industry Update - Process Validation FDA Guidance Update: Process Validation: General Principles and Practices White Paper FDA Guidance for Industry Update - Process Validation The changing face of Validation; are IQ, OQ and PQ really dead

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES NDA 17-854 NDA 21-793 NDA 17-862. [inside address] Dear :

DEPARTMENT OF HEALTH & HUMAN SERVICES NDA 17-854 NDA 21-793 NDA 17-862. [inside address] Dear : DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 NDA 17-854 [inside address] Dear : Please refer to your new drug application NDA xx-xxx for

More information

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors Frequently Asked Questions About Medical Devices Additional copies are available from: Office of Good Clinical Practice Office

More information

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not

More information

General Wellness: Policy for Low Risk Devices. Draft Guidance for Industry and Food and Drug Administration Staff

General Wellness: Policy for Low Risk Devices. Draft Guidance for Industry and Food and Drug Administration Staff General Wellness: Policy for Low Risk Devices Draft Guidance for Industry and Food and Drug Administration Staff DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document

More information

How To Regulate A Medical Device From A Cell Phone

How To Regulate A Medical Device From A Cell Phone On Behalf of: InTouch Health White Paper FDA Regulation of Mobile Health Technologies The Current Regulatory Framework as Applied to InTouch Health s Telemedicine Solution June 15, 2012 TABLE OF CONTENTS

More information

FDA Regulation of Health IT

FDA Regulation of Health IT FDA Regulation of Health IT May 2014 Marian J. Lee Partner King & Spalding +1 (202) 661 7955 mlee@kslaw.com Agenda FDA s Mobile Medical Applications Guidance FDASIA Health IT Report 2 FDA s Mobile Medical

More information

By Natalia Wilson, MD, MPH

By Natalia Wilson, MD, MPH White Paper The value of unique device identification across healthcare By Natalia Wilson, MD, MPH Executive summary The Unique Device Identification (UDI) System Proposed Rule was published by the U.S.

More information

Medical Device Reporting for User Facilities

Medical Device Reporting for User Facilities Medical Device Reporting for User Facilities DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Food and Drug Administration Medical Device Reporting for User Facilities Prepared by Office

More information

Overview. Introduction To The Revised GPSD

Overview. Introduction To The Revised GPSD KELLER AND HECKMAN LLP Serving Business through Law and Science The Revised EU General Product Safety Directive ( GPSD ) and the EU Product Liability Directive: Considerations for Global Consumer Product

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Bar Code Label Requirements Questions and Answers (Question 12 Update) DRAFT GUIDANCE This guidance document is for comment purposes only. Submit comments on this draft guidance by

More information

Unique Device Identification System; Final Rule

Unique Device Identification System; Final Rule 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Unique Device Identification System; Final Rule Docket No. FDA-2011-N-0090 Final Regulatory Impact Analysis Final Regulatory

More information

Case 1:15-cv-23419-XXXX Document 1 Entered on FLSD Docket 09/10/2015 Page 1 of 8

Case 1:15-cv-23419-XXXX Document 1 Entered on FLSD Docket 09/10/2015 Page 1 of 8 Case 1:15-cv-23419-XXXX Document 1 Entered on FLSD Docket 09/10/2015 Page 1 of 8 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF FLORIDA UNITED STATES OF AMERICA, ) ) Plaintiff, ) ) v.

More information

Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions

Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions U.S. Department of Health and Human Services Food and Drug Administration Center for

More information

WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE

WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 globalsales@maetrics.com

More information

0 EC2 92011 V-,) 133 Lj9a

0 EC2 92011 V-,) 133 Lj9a 0 EC2 92011 V-,) 133 Lj9a Section 5: 5 1 0(k) Summar 5 10(K) SUMMARY FOR SOMATOM DEFINITION Flash (with Stellar Detector) Submitted by: Siemens Medical Solutions USA, Inc. 51 Valley Stream Parkway Malvern,

More information

Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff

Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff Document issued on August 20, 2014. On November 5, 2014 this document was

More information

February 5, 2015. Dear Kristin Pabst,

February 5, 2015. Dear Kristin Pabst, DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 February 5, 2015, Inc.

More information

Strengthening Our national SyStem for medical device POStmarket Surveillance

Strengthening Our national SyStem for medical device POStmarket Surveillance Strengthening Our national SyStem for medical device POStmarket Surveillance center for devices and radiological health u.s. food and drug administration SEPTEMBER 2012 table Of contents a InTRoducTIon

More information

IVD Regulation Overview. Requirements to Assure Quality & Effectiveness

IVD Regulation Overview. Requirements to Assure Quality & Effectiveness IVD Regulation Overview Requirements to Assure Quality & Effectiveness CLIAC Jan. 2002 Statutory and Regulatory Requirements Statute: Food, Drug, and Cosmetic Act Food and Drugs Act of 1906 Food and Drug

More information

NOTICE OF PRIVACY PRACTICES Effective: September 20, 2013

NOTICE OF PRIVACY PRACTICES Effective: September 20, 2013 Livingston Hospital and Healthcare Services 131 Hospital Drive Salem, KY 42078. NOTICE OF PRIVACY PRACTICES Effective: September 20, 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE

More information

CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS:

CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS: CONDUCTING GLOBAL CLINICAL RESEARCH TRIALS: COMPARING AND CONTRASTING FDA MEDICAL DEVICE REGULATIONS FOR CLINICAL INVESTIGATORS WITH ISO 14155:2011 Introduction Today s clinical research landscape for

More information

GE Healthcare MAR 1 2013

GE Healthcare MAR 1 2013 K130155 Pagel1 of 2 GE Healthcare MAR 1 2013 510(k) Summary In accordance with 21 CFR 807.92 the following summary of information is provided: Submitter: Primary Contact Person: Secondary Contact Person:

More information

The Shifting Sands of Medical Software Regulation

The Shifting Sands of Medical Software Regulation The Shifting Sands of Medical Software Regulation Suzanne O Shea Ralph Hall September 10, 2014 What Software is Regulated by FDA? FDA regulates medical devices. FDA regulates software that meets the definition

More information

March 18, 2013. Discussion Guide

March 18, 2013. Discussion Guide March 18, 2013 Discussion Guide Unique Device Identification (UDI) Implementation Expert Workshop: Accessing & Communicating Device Information: UDI as a Tool for Improved Patient and Provider Connectivity

More information